
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
Division of Biochemistry, Chiba Cancer Center Research Institute, Chiba 260-8717 [H. T., T. O., A. N.]; Japanese Study Group for Pediatric Liver Tumor [H. H., E. H., T. M., Y. H., Y. W., S. S., M. K., F. S., K. H., N. O., A. N.]; and Division of Cell Biology, Cancer Institute, Hokkaido University School of Medicine, Sapporo 060-8638 [K. F., M. T.], Japan
Hepatoblastoma (HBL) is the most common malignant liver tumor in young children. Recent reports have shown that the ß-catenin gene was frequently mutated or deleted in HBLs. To elucidate the role of ß-catenin abnormalities in HBLs, we searched for mutations of ß-catenin and APC as well as expression of the target genes, cyclin D1, c-myc, and fibronectin, in 68 primary HBLs. The mutation analysis revealed that 44 (65%) tumors carried missense mutations or deletions of ß-catenin, all of which were somatic and targeted to the exon 3 encoding the amino acid residues involved in its degradation. However, no loss of function mutation of the APC gene was detected by the yeast functional assay. Of interest, ß-catenin mutation was significantly correlated with overexpression of the target genes, cyclin D1 and fibronectin, but not with that of c-myc in HBLs as measured by quantitative real-time reverse transcription-PCR. The immunohistochemical studies in 15 HBLs demonstrated that the nuclear/cytoplasmic accumulation of ß-catenin was positive in 13 tumors, 9 of which had the deletion or mutation of the gene. The significant correlation between the ß-catenin gene abnormality and the positive staining of cyclin D1 was also confirmed. Furthermore, the nuclear accumulation of ß-catenin was strongly associated with the poorly differentiated tumor cell components as well as with the positive staining of cyclin D1 within the tumor. Thus, our present results suggested that the gain of function mutation of ß-catenin played a crucial role in the malignant progression of HBL in vivo.
This article has been cited by other articles:
![]() |
D. Sinner, J. J. Kordich, J. R. Spence, R. Opoka, S. Rankin, S.-C. J. Lin, D. Jonatan, A. M. Zorn, and J. M. Wells Sox17 and Sox4 Differentially Regulate {beta}-Catenin/T-Cell Factor Activity and Proliferation of Colon Carcinoma Cells Mol. Cell. Biol., November 15, 2007; 27(22): 7802 - 7815. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamamoto, T. Ozaki, M. Nakanishi, H. Kikuchi, K. Yoshida, H. Horie, H. Kuwano, and A. Nakagawara Oxidative stress induces p53-dependent apoptosis in hepatoblastoma cell through its nuclear translocation Genes Cells, April 1, 2007; 12(4): 461 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Koch, A. Waha, W. Hartmann, A. Hrychyk, U. Schuller, A. Waha, K. A. Wharton Jr, S. Y. Fuchs, D. v. Schweinitz, and T. Pietsch Elevated Expression of Wnt Antagonists Is a Common Event in Hepatoblastomas Clin. Cancer Res., June 15, 2005; 11(12): 4295 - 4304. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kim, R. C. Sills, and C. D. Houle Overview of the Molecular Biology of Hepatocellular Neoplasms and Hepatoblastomas of the Mouse Liver Toxicol Pathol, January 1, 2005; 33(1): 175 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-P. Sher, J.-Y. Shih, P.-C. Yang, S. R. Roffler, Y.-W. Chu, C.-W. Wu, C.-L. Yu, and K. Peck Prognosis of Non-Small Cell Lung Cancer Patients by Detecting Circulating Cancer Cells in the Peripheral Blood with Multiple Marker Genes Clin. Cancer Res., January 1, 2005; 11(1): 173 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shiina, M. Igawa, J. Breault, L. Ribeiro-Filho, D. Pookot, S. Urakami, M. Terashima, M. Deguchi, M. Yamanaka, M. Shirai, et al. The Human T-Cell Factor-4 Gene Splicing Isoforms, Wnt Signal Pathway, and Apoptosis in Renal Cell Carcinoma Clin. Cancer Res., June 1, 2003; 9(6): 2121 - 2132. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wei, C.-A. Renard, C. Labalette, Y. Wu, L. Levy, C. Neuveut, X. Prieur, M. Flajolet, S. Prigent, and M.-A. Buendia Identification of the LIM Protein FHL2 as a Coactivator of beta -Catenin J. Biol. Chem., February 7, 2003; 278(7): 5188 - 5194. [Abstract] [Full Text] [PDF] |
||||
![]() |
V.-M. Wasenius, S. Hemmer, E. Kettunen, S. Knuutila, K. Franssila, and H. Joensuu Hepatocyte Growth Factor Receptor, Matrix Metalloproteinase-11, Tissue Inhibitor of Metalloproteinase-1, and Fibronectin Are Up-Regulated in Papillary Thyroid Carcinoma: A cDNA and Tissue Microarray Study Clin. Cancer Res., January 1, 2003; 9(1): 68 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhai, R. Wu, D. R. Schwartz, D. Darrah, H. Reed, F. T. Kolligs, M. T. Nieman, E. R. Fearon, and K. R. Cho Role of {beta}-Catenin/T-Cell Factor-Regulated Genes in Ovarian Endometrioid Adenocarcinomas Am. J. Pathol., April 1, 2002; 160(4): 1229 - 1238. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Abraham, D. S. Klimstra, R. E. Wilentz, C. J. Yeo, K. Conlon, M. Brennan, J. L. Cameron, T.-T. Wu, and R. H. Hruban Solid-Pseudopapillary Tumors of the Pancreas Are Genetically Distinct from Pancreatic Ductal Adenocarcinomas and Almost Always Harbor {beta}-catenin Mutations Am. J. Pathol., April 1, 2002; 160(4): 1361 - 1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Abraham, T.-T. Wu, R. H. Hruban, J.-H. Lee, C. J. Yeo, K. Conlon, M. Brennan, J. L. Cameron, and D. S. Klimstra Genetic and Immunohistochemical Analysis of Pancreatic Acinar Cell Carcinoma : Frequent Allelic Loss on Chromosome 11p and Alterations in the APC/{beta}-Catenin Pathway Am. J. Pathol., March 1, 2002; 160(3): 953 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Abraham, T.-T. Wu, D. S. Klimstra, L. S. Finn, J.-H. Lee, C. J. Yeo, J. L. Cameron, and R. H. Hruban Distinctive Molecular Genetic Alterations in Sporadic and Familial Adenomatous Polyposis-Associated Pancreatoblastomas : Frequent Alterations in the APC/{beta}-Catenin Pathway and Chromosome 11p Am. J. Pathol., November 1, 2001; 159(5): 1619 - 1627. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |